Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition
Executive Summary
As Andrew Witty takes the helm at GlaxoSmithKline, he has set his sights on tackling one of the industry's biggest challenges: reducing attrition in the late-stage pipeline